Skip to content

Effect of Peppermint Oil Inhalation on Postoperative Nausea, Vomiting and Comfort

Determination of the Effect of Peppermint Oil Inhalation on Postoperative Nausea, Vomiting and Comfort

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05585086
Enrollment
60
Registered
2022-10-18
Start date
2022-12-20
Completion date
2023-04-20
Last updated
2022-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inhalation; Oil

Keywords

patient, nausea, Vomiting, mentha piperita, postoperative

Brief summary

Nausea and vomitting related to drugs and anesthetic methods are among the important postoperative problems. Nausea and vomitting causing illlness feeling of patient are frequent after surgical interventions, cause increased dissatisfaction of the patient and prolonged discharge period. In this study it was aimed to evaluate the effect of peppermint oil inhalation on postoperative nausea and vomitting. Purpose and Type of Research The randomized controlled study will be performed on patients undergoing laparoscopic cholecystectomy, which is the most commonly performed surgical procedure, in a general surgery clinic of a training and research hospital.

Detailed description

Nausea and vomitting related to drugs and anesthetic methods are among the important postoperative problems. Nausea and vomitting causing illlness feeling of patient are frequent after surgical interventions, cause increased dissatisfaction of the patient and prolonged discharge period. In this study it was aimed to evaluate the effect of peppermint oil inhalation on postoperative nausea and vomitting. Purpose and Type of Research The randomized controlled study will be performed on patients undergoing laparoscopic cholecystectomy, which is the most commonly performed surgical procedure, in a general surgery clinic of a training and research hospital. Location of the research This research will be carried out in a 24-bed general surgery clinic of a 250-bed training and research hospital located in western Turkey. In the Surgery Service, nurses work in three shifts, 08:00-16:00, 16:00-24:00 and 24:00-08:00, while the responsible nurse works between 08:00-17:00. In the surgical service, there are a total of 24 patient rooms, all of which are single beds. Clinical routines in the surgery clinic include pharmacological methods and there is no use of complementary therapy methods. Population and Sample of the Research 60 patients are planned to be included in the study. In the creation of randomization; Experiment and control group will be assigned by computer method. In this way, experimental applications will be continued until the number of patients in both groups is completed. During the trial period, patients who wish to withdraw or need to be excluded from the trial will be excluded. Research Hypotheses H0. Peppermint oil inhalation has no effect on post-operative nausea. H1. Peppermint oil inhalation has an effect on post-operative nausea. H0. Peppermint oil inhalation has no effect on postoperative comfort. H0. Peppermint oil inhalation has an effect on postoperative comfort.

Interventions

OTHERPeppermint Oil Inhalation

Peppermint oil will be given by diluting 1/10 in wheat oil so that it does not cause skin irritation. Application; by inhalation method, 2 cc lavender essential oil + 100 cc water (2%) will be in the form of two drops for 20 minutes. Since the effectiveness of essential oils decreases over time and the desired dose cannot be applied at the same time; Peppermint oil will be applied to the individual for a total of 5 times every 30 minutes.

Sponsors

Kırklareli University
CollaboratorOTHER
Gümüşhane Universıty
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* over 18 years old, 65 years old and under, * having colonoscopy, * not having the risk of heart failure and cardiogenic shock (class III and IV), * not having a history of asthma, eczema and allergies to flowers and plants, * no peppermint oil allergy, * no communicative / severe hearing or speech impairment, * no use of antidepressant, antihistamine, diuretic, hypnotic, benzodiazepine and narcotic derivatives * ASA score of 1 or 2 * Individuals willing to participate will be included in the study.

Exclusion criteria

• Individuals who do not meet the inclusion criteria will not be included in the

Design outcomes

Primary

MeasureTime frameDescription
Nause7 daypost-operative nausea rate

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026